News
Texas Sues Eli Lilly for Allegedly Bribing Providers to Prescribe Its Medications
WASHINGTON (Reuters) -Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly "bribing" providers to prescribe its medications. The attorney general's office said in a statement the company bribed and illegally induced medical providers to prescribe its most profitable drugs,
Trump this month sent letters to the world’s largest drugmakers, including Lilly, insisting they lower what they charge ...
Eli Lilly ( NYSE: LLY) will raise the cost of its GLP-1/GIP receptor agonist Mounjaro (tirzepatide), approved for type 2 ...
Eli Lilly will increase the UK price of its Mounjaro treatment by 170% to match European markets. Despite Novo Nordisk's ...
Straight Arrow News on MSN16h
Eli Lilly accused of bribing doctors to prescribe Mounjaro and other drugs
Texas Attorney General Ken Paxton filed a lawsuit against Eli Lilly, accusing the drug maker of bribing doctors to prescribe ...
Pharma group seeks to address US complaints about ‘foreign freeloaders’ who rely on Americans to pay more for medicines ...
Eli Lilly is set to increase the UK price of its weight-loss and diabetes drug Mounjaro by 170%, aligning it with other ...
Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...
Eli Lilly and Company (NYSE:LLY) is one of the best upside stocks to invest in now. On August 11, Eli Lilly announced its decision to use the confidential reimbursement price option in Germany for its ...
Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers’ first choice for patients with Type 2 diabetes.
Investing.com -- Eli Lilly (NYSE:LLY) has increased the price of its weight loss drug Mounjaro in the United Kingdom by up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback